Abstract:Objective To investigate the expression of p21,p53 and c-erbB-2 in tissues of non-small cell lung cancer (NSCLC),and explore its clinical significance.Methods The clinical data and paraffin tissue samples of 207 patients with NSCLC confirmed by postoperative pathology were collected.The expression of p21,p53 and c-erbB-2 protein in tissues of NSCLC was detected by immunohistochemical method,the correlation among the expression of p21,p53 and c-erbB-2 protein was analysed,and the relationship between the expression of p21,p53 and c-erbB-2 protein and clinicopathological characteristics was explored.Results The expression of p21 was significantly positively related to that of p53 in tissues of NSCLC(r=0.245,P0.01).The positive expression rates of p21,p53 and c-erbB-2 in tissues of NSCLC were 54.11%,38.16%and 32.85%,respectively in 207 patients,and patients with poor differentiation,medium differentiation and lymph node metastasis had significantly higher expression than those with high differentiation and no lymph node metastasis(P0.05).Patients with history of smoking,central type and squamous carcinoma had higher positive expression rates of p21 and p53,and females and those with no history of smoking,peripheral type and adenocarcinoma had higher expression rates of c-erbB-2(P0.05).The 5-year survival rates of patients with positive expression of p21,p53 and c-erbB-2 in tissues of NSCLC were significantly lower than those with negative expression(P0.05).Conclusion p21,p53 and c-erbB-2 may play important roles in development and progression of NSCLC,which may serve as predicators for prognosis.

Expression of C-Erbb-2,nm23-h1 Proteins and PCNA in Pancreatic Adenocarcinoma and Its Clinical Significance

The Expression and Clinical Significance of PCNA and C-erbB-2 in Breast Cancer Tissue

Expression pattern of laminin 332α3 chain is correlated with invasion and metastasis of pancreatic ductal adenocarcinoma

Expression of E-cadherin and PCNA in pancreatic adenocarcinoma and their clinic significance

Expression of C-Erbb-2 and PCNA in Cervical Adenocarcinoma and Its Signification

Clinicopathological and related gene analysis in gastric adenocarcinoma and their correlation with prognosis

Clinical Significance of Expressions of P21 and P53 Proteins and PCNA in Pancreatic Cancer

Expression of C-Erbb-2,p53,pcna and Nm23 Proteins in Breast Cancer and Their Clinical Significance

A Relativily Study of ER,PR,p53 and PCNA Expressions in Endeometrical Adenocarcinoma

Expression of Oncoprotein C-Erbb-2 and Nm23h1 in Gallbladder Carcinoma and Its Significance

E-cadherin expression in pancreatic cancer and its clinical significance

Expression and significance of LC3 and cathepsin D in human endometrioid adenocarcinoma.

Expression and significant of EphA2、 EphrinAl and E-cadherin in pancreatic carcinoma

Expression of C-erbB-2 and nm23 proteins in breast cancer and their clinical signifi cance

Expression of P21, P53 and C-Erbb-2 in Tissues of Non-Small Cell Lung Cancer and Its Clinical Significance

Expressions and clinical significance of tumor markers in intestinal mucous adenocarcinoma

Expression and Clinical Significance of Ki-67,E-Cad and Nm23 in Human Invasive Pituitary Adenomas

Expression of Β-Catenin in Pancreatic Carcinoma and Its Significance to the Prognosis

Clinical significance of expression of HIF-1α and EMTrelated factors in pancreatic ductal adenocarcinoma

Emergence of heterogeneous nuclear ribonucleoprotein A2/B1 vs loss of E-cadherin: their reciprocal immunoexpression profiles in human pancreatic cancer.

Expression of ER,PR, C-erbB-2 and Ki-67 Genes in Breast Cancer and Their Clinical Significance